Solórzano SF

Language: Spanish
References: 8
Page: 53
PDF size: 94.29 Kb.

Text Extraction

No abstract

REFERENCES

1. Hu VH, Holland MJ, Burton MJ. Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Negl Trop Dis. 2013; 7:e2020.

2. Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009; 93: 563–568.

3. Taylor HR, Johnson SL, Prendergast RA, Schachter J, Dawson CR, et al. An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci 1982; 23: 507–515.

4. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985; 7: 717–725.

5. Morrison RP, Belland RJ, Lyng K, Caldwell HD Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 170: 1271–1283.

6. Holland MJ, Bailey RL, Hayes LJ, Whittle HC, Mabey DC Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J Infect Dis 1993; 168: 1528–1531.

7. Global WHO Alliance for the Elimination of Blinding Trachoma by 2020. Wkly Epidemiol Rec. 2012; 87:161-8.

8. Baneke A. Review: Targeting trachoma: Strategies to reduce the leading infectious cause of blindness. Travel Med Infect Dis 2012; 10:92-6.